{"id":"iv-levofloxacin","safety":{"commonSideEffects":[{"rate":"3-4%","effect":"Nausea"},{"rate":"2-3%","effect":"Diarrhea"},{"rate":"2-3%","effect":"Headache"},{"rate":"1-2%","effect":"Insomnia"},{"rate":"<1%","effect":"Tendinopathy"},{"rate":"<1%","effect":"QT prolongation"},{"rate":"<1%","effect":"Photosensitivity"},{"rate":"<1%","effect":"Peripheral neuropathy"}]},"_chembl":{"chemblId":"CHEMBL33","moleculeType":"Small molecule","molecularWeight":"361.37"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"As a fluoroquinolone antibiotic, levofloxacin is the active L-enantiomer of ofloxacin. It binds to and inhibits bacterial topoisomerases, enzymes essential for DNA unwinding and replication. This leads to accumulation of DNA breaks, cell death, and bactericidal activity against a broad spectrum of gram-positive and gram-negative bacteria.","oneSentence":"Levofloxacin inhibits bacterial DNA gyrase and topoisomerase IV, preventing DNA replication and transcription in susceptible microorganisms.","_ai_confidence":"high"},"_scrapedAt":"2026-03-27T23:50:27.531Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Community-acquired pneumonia"},{"name":"Acute bacterial sinusitis"},{"name":"Acute bacterial exacerbation of chronic bronchitis"},{"name":"Complicated urinary tract infection"},{"name":"Acute pyelonephritis"},{"name":"Uncomplicated urinary tract infection"},{"name":"Prostatitis"},{"name":"Skin and soft tissue infections"}]},"trialDetails":[{"nctId":"NCT06889701","phase":"PHASE1, PHASE2","title":"A Phase 1/2 Study to Evaluate the Safety, PK and Efficacy of TNP-2092 Administered Via IA Injection in PJI Participants","status":"RECRUITING","sponsor":"TenNor Therapeutics Inc.","startDate":"2025-04-03","conditions":"Periprosthetic Joint Infection (PJI)","enrollment":33},{"nctId":"NCT05398679","phase":"PHASE4","title":"Oral Antimicrobial Treatment vs. Outpatient Parenteral for Infective Endocarditis","status":"RECRUITING","sponsor":"Fundacion Clinic per a la Recerca Biomédica","startDate":"2022-08-17","conditions":"Endocarditis Infective","enrollment":360},{"nctId":"NCT02701608","phase":"PHASE3","title":"Oral Switch During Treatment of Left-sided Endocarditis Due to Multi-susceptible Staphylococcus","status":"COMPLETED","sponsor":"University Hospital, Tours","startDate":"2016-02-29","conditions":"Infective Endocarditis","enrollment":162},{"nctId":"NCT05074147","phase":"PHASE3","title":"Comparison Between Two Durations of Antibiotherapy for Non-surgically-treated Diabetic Foot Osteomyelitis (CHRONOS-2)","status":"WITHDRAWN","sponsor":"Tourcoing Hospital","startDate":"2022-05-01","conditions":"Osteomyelitis - Foot","enrollment":""},{"nctId":"NCT07332325","phase":"PHASE3","title":"STeroids and Enhanced Spectrum Antibiotics for the Treatment of Patients in Africa With Refractory Sepsis","status":"NOT_YET_RECRUITING","sponsor":"University of Virginia","startDate":"2026-04","conditions":"Sepsis, Tuberculosis","enrollment":344},{"nctId":"NCT05079620","phase":"PHASE4","title":"Early Antibiotics After Aspiration in ICU Patients","status":"TERMINATED","sponsor":"UConn Health","startDate":"2021-11-30","conditions":"Aspiration, Aspiration Pneumonia","enrollment":5},{"nctId":"NCT07240077","phase":"PHASE4","title":"Beta-lactam Plus Levofloxacin to Enhance Therapy in Streptococcal Septicemia","status":"NOT_YET_RECRUITING","sponsor":"Mahidol University","startDate":"2026-01-01","conditions":"Bacteremia, Streptococcus Infection","enrollment":165},{"nctId":"NCT05977868","phase":"PHASE4","title":"Comparing Oral Versus Parenteral Antimicrobial Therapy","status":"TERMINATED","sponsor":"West Virginia University","startDate":"2023-08-04","conditions":"Endovascular Infection, Bone and Joint Infection, Skin and Soft Tissue Infection","enrollment":94},{"nctId":"NCT06977347","phase":"NA","title":"Appropriateness of Antibiotic Combination Therapy for Severe Community-acquired Pneumonia in South Korea","status":"NOT_YET_RECRUITING","sponsor":"CHOSEOK YOON","startDate":"2025-06-15","conditions":"Severe Community-acquired Pneumonia (sCAP)","enrollment":100},{"nctId":"NCT05302531","phase":"PHASE1","title":"Absorption of Antibiotics With High Oral Bioavailability in Short-bowel Syndrome","status":"RECRUITING","sponsor":"Central Hospital, Nancy, France","startDate":"2022-12-09","conditions":"Short Bowel Syndrome, Infection, Bacterial","enrollment":10},{"nctId":"NCT05867654","phase":"PHASE4","title":"Efficacy of Oral vs IV Antibiotics in the Treatment of Orofacial Osteomyelitis","status":"NOT_YET_RECRUITING","sponsor":"University of Louisville","startDate":"2024-07-31","conditions":"Osteomyelitis of Jaw","enrollment":100},{"nctId":"NCT02735707","phase":"PHASE3","title":"Randomized, Embedded, Multifactorial Adaptive Platform Trial for Community- Acquired Pneumonia","status":"RECRUITING","sponsor":"UMC Utrecht","startDate":"2016-04-11","conditions":"Community-acquired Pneumonia, Influenza, COVID-19","enrollment":20000},{"nctId":"NCT05156437","phase":"PHASE4","title":"Postoperative Antibiotic Management Duration Following Surgery for Intravenous Drug Abuse (IVDA) Endocarditis (OPTIMAL)","status":"ENROLLING_BY_INVITATION","sponsor":"Vinay Badhwar","startDate":"2022-03-16","conditions":"Endocarditis","enrollment":20},{"nctId":"NCT02409290","phase":"PHASE3","title":"The Evaluation of a Standard Treatment Regimen of Anti-tuberculosis Drugs for Patients With MDR-TB","status":"COMPLETED","sponsor":"IUATLD, Inc","startDate":"2016-03","conditions":"MDR-TB","enrollment":588},{"nctId":"NCT02357407","phase":"PHASE4","title":"Development of an Adjustment Assistance Tool Dosage of Fluoroquinolones in a Population Pharmacokinetic Model","status":"COMPLETED","sponsor":"Rennes University Hospital","startDate":"2015-06","conditions":"Infection","enrollment":31},{"nctId":"NCT02800785","phase":"NA","title":"The Comparison of Outcomes of Antibiotic Drugs and Appendectomy (CODA) Trial","status":"COMPLETED","sponsor":"University of Washington","startDate":"2016-05","conditions":"Appendicitis","enrollment":1552},{"nctId":"NCT05393505","phase":"PHASE4","title":"Fast-track Blood Test for Suspected Fever by Deficiency of a Kind of White Blood Cells As Main Defense Against Infection","status":"UNKNOWN","sponsor":"The University of Hong Kong","startDate":"2022-10-24","conditions":"Neutropenic Fever","enrollment":344},{"nctId":"NCT05293977","phase":"NA","title":"Short-Term Use of Antibiotics and Adherence Level","status":"COMPLETED","sponsor":"Jordan University of Science and Technology","startDate":"2020-08-03","conditions":"Acute Infection","enrollment":589},{"nctId":"NCT00659646","phase":"PHASE2","title":"The Safety and Efficacy of an Antibiotic Sponge in Diabetic Patients With Moderately Infected Foot Ulcers","status":"COMPLETED","sponsor":"Innocoll","startDate":"2008-04","conditions":"Diabetic Foot Ulcer","enrollment":56},{"nctId":"NCT01978938","phase":"PHASE3","title":"Efficacy and Safety Study of Eravacycline Compared With Levofloxacin in Complicated Urinary Tract Infections","status":"COMPLETED","sponsor":"Tetraphase Pharmaceuticals, Inc","startDate":"2014-10-06","conditions":"cUTI","enrollment":908},{"nctId":"NCT03032510","phase":"PHASE3","title":"Efficacy and Safety Study of Eravacycline Compared With Ertapenem in Participants With Complicated Urinary Tract Infections","status":"COMPLETED","sponsor":"Tetraphase Pharmaceuticals, Inc","startDate":"2017-01","conditions":"Complicated Urinary Tract Infections","enrollment":1205},{"nctId":"NCT01109823","phase":"PHASE3","title":"Pharmacokinetic Evaluation of Fluoroquinolone Antibiotics Administered Intravenously in Intensive Care Patients With Normal Renal Function and With Renal Hyperfiltration","status":"COMPLETED","sponsor":"University Ghent","startDate":"2010-05-19","conditions":"Infection","enrollment":14},{"nctId":"NCT03768869","phase":"PHASE3","title":"Fever and Neutropenia in Pediatric Oncology Patients","status":"WITHDRAWN","sponsor":"University of Colorado, Denver","startDate":"2006-02","conditions":"Fever, Neutropenia","enrollment":""},{"nctId":"NCT02099240","phase":"EARLY_PHASE1","title":"Patients Response to Early Switch To Oral:Osteomyelitis Study","status":"TERMINATED","sponsor":"Julio Ramirez","startDate":"2014-03-06","conditions":"Osteomyelitis","enrollment":11},{"nctId":"NCT03697993","phase":"PHASE4","title":"Safety and Efficacy Study of Oral Fosfomycin Versus Oral Levofloxacin to Treat Complicated Urinary Syndromes (FOCUS)","status":"TERMINATED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2018-11-07","conditions":"Urinary Tract Infection","enrollment":62},{"nctId":"NCT01371656","phase":"PHASE3","title":"Levofloxacin in Preventing Infection in Young Patients With Acute Leukemia Receiving Chemotherapy or Undergoing Stem Cell Transplantation","status":"COMPLETED","sponsor":"Children's Oncology Group","startDate":"2011-09","conditions":"Acute Leukemias of Ambiguous Lineage, Bacterial Infection, Diarrhea","enrollment":624},{"nctId":"NCT03757234","phase":"PHASE2","title":"IV or IV/PO Omadacycline vs. IV/PO Levofloxacin for the Treatment of Acute Pyelonephritis","status":"COMPLETED","sponsor":"Paratek Pharmaceuticals Inc","startDate":"2018-11-19","conditions":"Acute Pyelonephritis","enrollment":201},{"nctId":"NCT01951768","phase":"PHASE4","title":"Efficacy and Safety of Garamycin® Sponge in Diabetic Patients With a Moderate or Severe Foot Ulcer Infection","status":"COMPLETED","sponsor":"University Hospital, Geneva","startDate":"2013-09","conditions":"Diabetic Foot Ulcer","enrollment":88},{"nctId":"NCT03409679","phase":"PHASE3","title":"Pivotal Study in VAP Suspected or Confirmed to be Due to Pseudomonas Aeruginosa","status":"TERMINATED","sponsor":"Polyphor Ltd.","startDate":"2018-03-23","conditions":"Pneumonia","enrollment":41},{"nctId":"NCT01756924","phase":"PHASE2","title":"Safety and Efficacy of CEM-102 With Rifampin Compared to Standard Therapy in Patients With Prosthetic Joint Infections or Spacer Infection","status":"TERMINATED","sponsor":"Arrevus Inc.","startDate":"2012-12","conditions":"Prosthetic Joint Infections of Hip, Prosthetic Joint Infections of Knee, Infected Spacers","enrollment":14},{"nctId":"NCT01345929","phase":"PHASE3","title":"Study Comparing the Safety and Efficacy of Intravenous CXA-201 and Intravenous Levofloxacin in Complicated Urinary Tract Infection, Including Pyelonephritis","status":"COMPLETED","sponsor":"Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)","startDate":"2011-06-20","conditions":"Complicated Urinary Tract Infection, Pyelonephritis","enrollment":558},{"nctId":"NCT02486627","phase":"PHASE3","title":"A Study of Plazomicin Compared With Meropenem for the Treatment of Complicated Urinary Tract Infection (cUTI) Including Acute Pyelonephritis (AP)","status":"COMPLETED","sponsor":"Achaogen, Inc.","startDate":"2016-01-11","conditions":"Complicated Urinary Tract Infection, Acute Pyelonephritis","enrollment":609},{"nctId":"NCT01096849","phase":"PHASE2","title":"A Study of Plazomicin Compared With Levofloxacin for the Treatment of Complicated Urinary Tract Infection (cUTI) and Acute Pyelonephritis (AP)","status":"COMPLETED","sponsor":"Achaogen, Inc.","startDate":"2010-07-13","conditions":"Complicated Urinary Tract Infection, Acute Pyelonephritis","enrollment":145},{"nctId":"NCT03622450","phase":"PHASE2, PHASE3","title":"The Effect of Colistin Inhalation on Ventilator Associated Pneumonia","status":"COMPLETED","sponsor":"Nourhan Hassan Osama Thuraya Mohamed","startDate":"2016-01-02","conditions":"Ventilator Associated Pneumonia","enrollment":40},{"nctId":"NCT02166476","phase":"PHASE3","title":"Efficacy/Safety of Meropenem-Vaborbactam Compared to Piperacillin-Tazobactam in Adults With cUTI and AP","status":"COMPLETED","sponsor":"Melinta Therapeutics, Inc.","startDate":"2014-11-20","conditions":"Urinary Tract Infection Complicated, Acute Pyelonephritis","enrollment":550},{"nctId":"NCT00176306","phase":"PHASE4","title":"Levofloxacin Pharmacokinetics (PK) in the Severely Obese","status":"COMPLETED","sponsor":"Joel Thompson, PhD","startDate":"2005-01","conditions":"Obesity, Critical Illness","enrollment":15},{"nctId":"NCT02618057","phase":"PHASE4","title":"Effects of Oral Steroid in Mycoplasma Pneumoniae Pneumonia","status":"UNKNOWN","sponsor":"Seoul National University Hospital","startDate":"2016-06","conditions":"Mycoplasma Pneumoniae Pneumonia","enrollment":80},{"nctId":"NCT02901288","phase":"PHASE4","title":"Shortened Regimens for Drug-susceptible Pulmonary Tuberculosis","status":"UNKNOWN","sponsor":"Beijing Chest Hospital","startDate":"2016-08","conditions":"Tuberculosis, Pulmonary","enrollment":3900},{"nctId":"NCT00035347","phase":"PHASE4","title":"Intravenous Azithromycin Plus Intravenous Ceftriaxone Followed by Oral Azithromycin With Intravenous Levofloxacin Followed by Oral Levofloxacin for the Treatment of Moderate to Severely Ill Hospitalized Patients With Community Acquired Pneumonia","status":"COMPLETED","sponsor":"Pfizer","startDate":"2001-01","conditions":"Community-Acquired Pneumonia (CAP)","enrollment":219},{"nctId":"NCT00596167","phase":"NA","title":"Intradialytic Drug Removal by Short-daily Hemodialysis","status":"COMPLETED","sponsor":"Indiana University School of Medicine","startDate":"2007-09","conditions":"End Stage Renal Disease, Infection","enrollment":6},{"nctId":"NCT01875263","phase":"PHASE3","title":"Efficacy of a Short-term Sequential Therapy in Non-complicated Catheter Related Bacteremia by Methicillin- Susceptible S.Aureus.","status":"TERMINATED","sponsor":"Fundación Pública Andaluza Progreso y Salud","startDate":"2013-05","conditions":"Staphylococcus","enrollment":1},{"nctId":"NCT00250718","phase":"PHASE2","title":"Study: Treatment of Relapsed Lymphoid Malignancies With an Anti-Angiogenic Approach","status":"TERMINATED","sponsor":"New Mexico Cancer Research Alliance","startDate":"2004-10","conditions":"Non-Hodgkin's Lymphoma, Cancer","enrollment":17},{"nctId":"NCT00431678","phase":"PHASE3","title":"Efficacy and Safety of Sequential IV/PO Moxifloxacin in Comparison to IV Levofloxacin Plus IV Ceftriaxone Followed by PO Levofloxacin, in the Treatment of Patients With Community-acquired Pneumonia","status":"COMPLETED","sponsor":"Bayer","startDate":"2004-01","conditions":"Pneumonia","enrollment":738},{"nctId":"NCT00665327","phase":"PHASE4","title":"Avelox for Treatment of Elderly Patients With Community Acquired Pneumonia","status":"COMPLETED","sponsor":"Bayer","startDate":"2002-11","conditions":"Pneumonia","enrollment":401},{"nctId":"NCT01757236","phase":"PHASE2","title":"Efficacy and Safety Study of Antibiotic Treatment to Treat Hip Prosthetic Joint Infection","status":"UNKNOWN","sponsor":"University Hospital, Tours","startDate":"2012-10","conditions":"Hip Prosthetic Joint Infection","enrollment":100},{"nctId":"NCT02123628","phase":"PHASE4","title":"Antibiotic Treatment Duration for Non-Surgically-Treated Diabetic Foot Osteomyelitis","status":"COMPLETED","sponsor":"Tourcoing Hospital","startDate":"2007-06","conditions":"Diabetes Mellitus","enrollment":40},{"nctId":"NCT00020865","phase":"PHASE3","title":"Levofloxacin Compared With Cefepime in Treating Cancer Patients With Fever and Neutropenia","status":"UNKNOWN","sponsor":"Jonsson Comprehensive Cancer Center","startDate":"2001-09","conditions":"Fever, Sweats, and Hot Flashes, Infection, Leukemia","enrollment":""},{"nctId":"NCT00005590","phase":"PHASE3","title":"Levofloxacin to Prevent Infection Following Chemotherapy in Treating Patients With Solid Tumors or Lymphoma","status":"COMPLETED","sponsor":"Cancer Research Campaign Clinical Trials Centre","startDate":"1999-08","conditions":"Brain and Central Nervous System Tumors, Breast Cancer, Extragonadal Germ Cell Tumor","enrollment":""},{"nctId":"NCT00752947","phase":"PHASE4","title":"Efficacy and Safety Trial to Assess Moxifloxacin in Treating Community-Acquired Pneumonia (CAP) With Aspiration Factors","status":"UNKNOWN","sponsor":"Beijing Hospital","startDate":"2008-09","conditions":"Community-Acquired Pneumonia","enrollment":186},{"nctId":"NCT00645073","phase":"PHASE4","title":"Study of the Safety and Efficacy of Cefdinir and Levofloxacin for the Treatment of Subjects With Acute Bacterial Sinusitis","status":"COMPLETED","sponsor":"Abbott","startDate":"2003-11","conditions":"Acute Bacterial Sinusitis","enrollment":271},{"nctId":"NCT00548002","phase":"","title":"Combination Therapy With Fluoroquinolone in Staphylococcus Aureus Bacteremia","status":"COMPLETED","sponsor":"University of Helsinki","startDate":"1999-01","conditions":"Staphylococcus Aureus, Bacteremia, Endocarditis","enrollment":430}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":19,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Levaquin®"],"phase":"marketed","status":"active","brandName":"IV levofloxacin","genericName":"IV levofloxacin","companyName":"Pfizer","companyId":"pfizer","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Levofloxacin inhibits bacterial DNA gyrase and topoisomerase IV, preventing DNA replication and transcription in susceptible microorganisms. Used for Community-acquired pneumonia, Acute bacterial sinusitis, Acute bacterial exacerbation of chronic bronchitis.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}